These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 25579070)
1. Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients. Stergiopoulou T; Walsh TJ Expert Opin Pharmacother; 2015 Feb; 16(2):213-26. PubMed ID: 25579070 [TBL] [Abstract][Full Text] [Related]
2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
4. Current status of antifungal resistance and its impact on clinical practice. Alcazar-Fuoli L; Mellado E Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533 [TBL] [Abstract][Full Text] [Related]
5. Antifungal treatment in pediatric patients. Zaoutis TE; Benjamin DK; Steinbach WJ Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422 [TBL] [Abstract][Full Text] [Related]
6. Strategies to manage antifungal drug resistance. Tseng HK; Perfect JR Expert Opin Pharmacother; 2011 Feb; 12(2):241-56. PubMed ID: 21226635 [TBL] [Abstract][Full Text] [Related]
7. Caspofungin acetate for treatment of invasive fungal infections. Pacetti SA; Gelone SP Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942 [TBL] [Abstract][Full Text] [Related]
8. Voriconazole : a review of its use in the management of invasive fungal infections. Scott LJ; Simpson D Drugs; 2007; 67(2):269-98. PubMed ID: 17284090 [TBL] [Abstract][Full Text] [Related]
9. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies. Gamaletsou MN; Walsh TJ; Sipsas NV Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334 [TBL] [Abstract][Full Text] [Related]
11. The value of amphotericin B in the treatment of invasive fungal infections. Klepser M J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541 [TBL] [Abstract][Full Text] [Related]
15. New antifungal agents in pediatric practice. Das S; Shivaprakash MR; Chakrabarti A Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570 [TBL] [Abstract][Full Text] [Related]
16. Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy. Hof H Mycoses; 2008; 51 Suppl 1():1-6. PubMed ID: 18471155 [TBL] [Abstract][Full Text] [Related]
18. Molecular Evolution of Antifungal Drug Resistance. Robbins N; Caplan T; Cowen LE Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681 [TBL] [Abstract][Full Text] [Related]
19. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance. Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605 [TBL] [Abstract][Full Text] [Related]
20. Does the current treatment of invasive fungal infection need to be reviewed? Martín-Peña A; Aguilar-Guisado M; Cisneros JM Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):523-8. PubMed ID: 23587702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]